Open Access Research article

Phase I study of TP300 in patients with advanced solid tumors with pharmacokinetic, pharmacogenetic and pharmacodynamic analyses

D A Anthoney, Jay Naik, Iain RJ MacPherson, Donna Crawford, John M Hartley, Janet A Hartley, Tomohisa Saito, Masaichi Abe, Keith Jones, Masanori Miwa, Christopher Twelves* and TRJ Evans

BMC Cancer 2012, 12:536 doi:10.1186/1471-2407-12-536

No comments have yet been made on this article.

Post a comment